A1. Novel Agents
Poster Session: Novel Agents
Motoyasu Onishi, PhD
Manager
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
Hidenori Yamashiro
subgroup leader
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
Joshua Maher, PhD
Research Scientist
JMI Laboratories
North Liberty, Iowa, United States
Hank Kimbrough, PhD
Element Materials Technology/Jones Microbiology Institute
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)
Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States
Boudewijn L. DeJonge, PhD (he/him/his)
Director Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
Sean T. Nguyen, PharmD
Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States
Christopher M. Longshaw, PhD
Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom
Miki Takemura, n/a
Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)
Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan